SEC Form 4 · accession 0001437749-16-038510
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Reay Code
Officer — Chief Science Officer · Director · 10% Owner
Period of report
Sep 7, 2016
Accepted (ET)
Sep 8, 2016 · 5:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880242
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 7, 2016 | G | 500,000 | $0.00 | D | 24,253,707 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.